Gabelli Funds LLC Biomarin Pharmaceutical Inc Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gabelli Funds LLC holds 12,839 shares of BMRN stock, worth $814,249. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,839

Previous 8,039 59.71%

Holding current value

$814,249

Previous $661,000 36.46%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $331,296 - $450,432	4,800 Added 59.71%	12,839 $902,000
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $82,915 - $102,733	1,114 Added 16.09%	8,039 $661,000
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $20,952 - $24,750	-250 Reduced 3.48%	6,925 $604,000
Q4 2023 Feb 13, 2024	SELL	$76.22 - $98.51 $78,506 - $101,465	-1,030 Reduced 12.55%	7,175 $691,000
Q3 2023 Nov 08, 2023	SELL	$85.07 - $94.48 $42,535 - $47,240	-500 Reduced 5.74%	8,205 $725,000
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $7,367 - $8,525	-85 Reduced 0.97%	8,705 $754,000
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $22,373 - $29,903	255 Added 2.99%	8,790 $854,000
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $816,179 - $1.1 Million	-10,085 Reduced 54.16%	8,535 $883,000
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $20,540 - $24,235	250 Added 1.36%	18,620 $1.58 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $53,610 - $65,137	750 Added 4.26%	18,370 $1.52 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $194,613 - $242,847	-2,620 Reduced 12.94%	17,620 $1.36 Million
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $985,432 - $1.26 Million	-13,740 Reduced 40.44%	20,240 $1.79 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $4,486 - $5,128	60 Added 0.18%	33,980 $2.63 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $56,632 - $63,592	-750 Reduced 2.16%	33,920 $2.83 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $2.18 Million - $2.65 Million	29,170 Added 530.36%	34,670 $2.62 Million
Q4 2020 Feb 05, 2021	BUY	$72.61 - $90.2 $125,252 - $155,595	1,725 Added 45.7%	5,500 $482,000
Q3 2020 Nov 06, 2020	BUY	$71.87 - $131.03 $131,162 - $239,129	1,825 Added 93.59%	3,775 $287,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $155,122 - $242,229	1,950 New	1,950 $241,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Biomarin Pharmaceutical Inc Transaction History